Physician profile
Latanya K Wright
NPI 1538398664
$971.76
in general payments reported to CMS, 2019-2025
11 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $42.45 · 2022: $172 · 2023: $254 · 2024: $188 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $757.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $310.21 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Exact Sciences Corporation | $194.99 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $125.00 | 2023 | |
| Vanda Pharmaceuticals INC. | $101.26 | 2025 | Fanapt |
| Novartis Pharmaceuticals Corporation | $81.62 | 2021-2022 | |
| Dexcom, INC. | $42.98 | 2023 | Dexcom G6 Transmitter |
| Alnylam Pharmaceuticals INC. | $27.14 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $26.50 | 2021-2022 | |
| Genentech USA, INC. | $23.72 | 2022 | |
| Novo Nordisk INC | $22.55 | 2022 | |
| Global Blood Therapeutics, INC. | $15.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Latanya Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.